SMTL ID : 2vya.1

Crystal Structure of fatty acid amide hydrolase conjugated with the drug-like inhibitor PF-750

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.75 Å

Oligo State

homo-dimer

Ligands

4 x UNX: UNKNOWN ATOM OR ION(Non-functional Binders)

UNX.1: 5 residues within 4Å: Chain A: M.199, S.225, S.249 Ligands: UNX.2, PF7.3 No protein-ligand interaction detected (PLIP) UNX.2: 6 residues within 4Å: Chain A: T.244, D.245, I.246, L.286 Ligands: UNX.1, PF7.3 No protein-ligand interaction detected (PLIP) UNX.4: 5 residues within 4Å: Chain B: M.199, S.225, S.249 Ligands: UNX.5, PF7.7 No protein-ligand interaction detected (PLIP) UNX.5: 6 residues within 4Å: Chain B: T.244, D.245, I.246, L.286 Ligands: UNX.4, PF7.7 No protein-ligand interaction detected (PLIP)

2 x PF7: 4-(quinolin-3-ylmethyl)piperidine-1-carboxylic acid

PF7.3: 17 residues within 4Å: Chain A: M.199, F.200, S.201, Y.202, D.245, I.246, G.247, G.248, S.249, T.385, F.389, F.440, M.444, T.496, V.499 Ligands: UNX.1, UNX.2 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:F.389, A:F.440, A:F.440, A:V.499 Hydrogen bonds: A:I.246, A:G.247, A:S.249 pi-Stacking: A:F.200 PF7.7: 18 residues within 4Å: Chain B: M.199, F.200, S.201, Y.202, S.225, D.245, I.246, G.247, G.248, S.249, T.385, F.389, F.440, M.444, T.496, V.499 Ligands: UNX.4, UNX.5 10 PLIP interactions: 10 interactions with chain B Hydrophobic interactions: B:F.200, B:F.389, B:F.440, B:F.440, B:T.496, B:V.499 Hydrogen bonds: B:I.246, B:G.247, B:S.249, B:T.496

1 x CL: CHLORIDE ION(Non-functional Binders)

CL.6: 4 residues within 4Å: Chain A: N.267, W.564 Chain B: N.267, W.564 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Mileni, M. et al., Structure-Guided Inhibitor Design for Human Faah by Interspecies Active Site Conversion. Proc.Natl.Acad.Sci.USA (2008)

Release Date

2008-09-09

Peptides

FATTY-ACID AMIDE HYDROLASE 1: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

FATTY-ACID AMIDE HYDROLASE 1